| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | CVS HEALTH CORP CMN | Jun 2, 2026 | |
| Buy | CVS HEALTH CORP CMN | May 22, 2026 | |
| Buy | CVS Health Corporation Commo | Mar 27, 2026 | |
| Sell | CVS HEALTH CORPORATION CMN | Mar 5, 2026 | |
| Buy | CVS AS STREET CORPORATION | Feb 24, 2026 | |
| Sell | CVS HEALTH CORPORATION, CMN | Feb 24, 2026 | |
| Buy | COHERENT CORP | Feb 22, 2026 | |
| Buy | CVS HEALTH CORP | Feb 21, 2026 | |
| Buy | CVS HEALTH CORPORATION CMN | Feb 17, 2026 | |
| Sell | CVS HEALTH CORP CMN | Feb 6, 2026 |
This page tracks congressional stock trading activity in CVS Health Corporation (CVS) in the company_delisted sector. Disclosed Capitol has indexed 406 disclosed congressional trades involving CVS. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of August 2026 — Disclosed Capitol has tracked 406 disclosed congressional trades in CVS Health Corporation (CVS) — 181:135 sell-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 2, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 22, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Mar 27, 2026 | Alan Armstrong | R | Buy | $1,001 - $15,000 |
| Mar 5, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| Feb 24, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Feb 24, 2026 | Ro Khanna | D | Sell | $15,001 - $50,000 |
| Feb 22, 2026 | Michael McCaul | R | Buy | $15,001 - $50,000 |
| Feb 21, 2026 | Michael McCaul | R | Buy | $1,001 - $15,000 |
| Feb 17, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Feb 6, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
Across the 406 disclosed congressional trades in CVS Health Corporation (CVS), members of Congress have reported 135 buys and 181 sells. The average 30-day alpha vs. the S&P 500 is 0.03%.
For fiscal year 2025, CVS Health Corporation reported revenue of $402.07B and net income of $1.77B, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $106.10B, net income $2.98B.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.